Unm Hospital

Unm Hospital was paid $463.29M by Medicaid between Jan 2018 and Dec 2024, across 1105 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 16% of everything it billed.

Compared with peers

Next to other Clinical Psychologist providers in New Mexico

Rank by total paid#1 of 39

Median peer was paid$84K

This provider vs. median5,483×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,209,785	$78.53M
2019	971,131	$65.64M
2020	796,299	$53.43M
2021	884,856	$56.74M
2022	969,528	$64.28M
2023	1,083,037	$70.84M
2024incomplete	1,082,213	$73.83M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	16%	909,870	749,869	$72.29M
G9001	Coordinated care fee, initial rate	6.8%	91,583	91,079	$31.64M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.6%	115,115	107,233	$16.57M
95004	Percutaneous tests with allergenic extracts, immediate type reaction	2.6%	2,843	2,767	$12.10M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.3%	40,547	37,204	$10.53M
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	2.3%	91,152	89,785	$10.52M
G0378	Hospital observation service, per hour	2.2%	24,139	21,969	$10.20M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	1.9%	49,773	45,750	$8.70M
A0430	Ambulance service, conventional air services, transport, one way (fixed wing)	1.4%	3,243	3,036	$6.53M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.4%	2,076	1,577	$6.41M
J9271	Injection, pembrolizumab, 1 mg	1.4%	817	620	$6.40M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.3%	22,123	21,162	$5.81M

1093 more codes

70450	Computed tomography, head or brain; without contrast material	1.1%	26,872	$5.17M
A0435	Fixed wing air mileage, per statute mile	1.1%	3,242	$5.03M
99214	Doctor's office visit, returning patient (more involved)	<1%	80,634	$4.10M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	70,277	$4.04M
J9312	Injection, rituximab, 10 mg	<1%	784	$3.90M
80048	Basic metabolic panel (calcium, ionized)	<1%	229,644	$3.48M
H2017	Psychosocial rehabilitation, billed per 15 minutes	<1%	35,903	$3.40M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	5,747	$3.28M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	75,741	$3.05M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	5,751	$3.04M
H0039	Assertive community treatment, face-to-face, per 15 minutes	<1%	18,439	$3.00M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	11,516	$3.00M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	54,957	$2.86M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	7,024	$2.85M
H2033	Multisystemic therapy for juveniles, per 15 minutes	<1%	10,555	$2.76M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	6,135	$2.70M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	30,150	$2.42M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	26,574	$2.31M
99213	Doctor's office visit, returning patient (routine)	<1%	57,867	$2.22M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	18,781	$2.21M
71046	Radiologic examination, chest; 2 views	<1%	44,240	$2.19M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	26,777	$2.17M
72125	Computed tomography, cervical spine; without contrast material	<1%	8,787	$2.05M
71275	Computed tomographic angiography, chest, with contrast material	<1%	5,458	$1.90M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	40,154	$1.87M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	18,224	$1.86M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	5,572	$1.83M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	4,468	$1.78M
G0390	Trauma response team associated with hospital critical care service	<1%	1,189	$1.77M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	1,154	$1.73M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	21,203	$1.72M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	41,522	$1.71M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	139,585	$1.70M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	12,582	$1.63M
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	1,716	$1.62M
90837	Psychotherapy session, about an hour	<1%	17,241	$1.62M
77386		<1%	3,746	$1.57M
80076		<1%	118,249	$1.55M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	40,183	$1.55M
96375	Therapeutic injection; each additional sequential IV push	<1%	36,059	$1.54M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	9,396	$1.52M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	4,104	$1.51M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	17,715	$1.50M
70498		<1%	4,740	$1.49M
J2505	Injection, pegfilgrastim, 6 mg	<1%	484	$1.43M
92587		<1%	12,518	$1.43M
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	921	$1.42M
H2015	Community support for mental illness or disability, per 15 minutes	<1%	12,149	$1.39M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	37,802	$1.38M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,821	$1.36M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	591	$1.33M
84443	Thyroid stimulating hormone (TSH)	<1%	55,156	$1.33M
76770		<1%	12,133	$1.31M
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,940	$1.30M
76819	Fetal biophysical profile; without non-stress testing	<1%	10,702	$1.26M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	48,067	$1.24M
99215	Doctor's office visit, returning patient (complex)	<1%	16,481	$1.24M
73610		<1%	13,383	$1.22M
73130		<1%	18,138	$1.20M
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	3,191	$1.19M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	24,389	$1.18M
Q3014	Telehealth originating site facility fee	<1%	30,532	$1.17M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,849	$1.17M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	769	$1.16M
85027		<1%	135,027	$1.16M
73562		<1%	12,739	$1.09M
A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	<1%	482	$1.06M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	16,962	$1.03M
93976		<1%	8,877	$1.01M
J9299	Injection, nivolumab, 1 mg	<1%	132	$992K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	2,891	$981K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	42,669	$976K
73630		<1%	14,826	$976K
T1007	Alcohol and/or substance abuse services, treatment plan development and/or modification	<1%	7,446	$960K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	3,279	$948K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	5,205	$945K
20610		<1%	9,642	$938K
73110		<1%	13,571	$934K
83036	Hemoglobin; glycosylated (A1C)	<1%	67,914	$932K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	18,899	$917K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	1,541	$894K
99232	Hospital visit by a doctor, follow-up day	<1%	17,060	$887K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,149	$886K
59025	Fetal non-stress test	<1%	7,882	$861K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	19,135	$854K
72170		<1%	9,549	$854K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	43,513	$850K
94010		<1%	6,418	$847K
97597		<1%	12,558	$827K
86003		<1%	1,730	$812K
71045	Radiologic examination, chest; single view	<1%	18,287	$809K
73030		<1%	10,113	$800K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	824	$800K
90472	Immunization administration, each additional vaccine (list separately)	<1%	24,113	$782K
74183		<1%	2,016	$771K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	354	$763K
81513		<1%	7,478	$757K
93325		<1%	8,543	$752K
20553		<1%	5,536	$746K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,245	$744K
90870		<1%	1,943	$742K
87086	Culture, bacterial; quantitative colony count, urine	<1%	49,556	$736K
0225U		<1%	3,635	$735K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	6,090	$729K
20680		<1%	460	$715K
72082		<1%	5,905	$711K
J9310	Injection, rituximab, 100 mg	<1%	160	$699K
43235		<1%	1,625	$694K
99203	Doctor's office visit, new patient (routine)	<1%	12,539	$691K
72141		<1%	2,229	$675K
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	3,379	$671K
95811		<1%	1,027	$670K
73080		<1%	9,156	$670K
73590		<1%	10,009	$666K
80061	Lipid panel	<1%	42,845	$658K
J0897	Injection, denosumab, 1 mg	<1%	998	$653K
70486		<1%	3,139	$645K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	8,573	$639K
70496		<1%	2,348	$639K
92557		<1%	5,825	$630K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	5,764	$630K
A0436	Rotary wing air mileage, per statute mile	<1%	482	$630K
84702		<1%	28,913	$629K
96361	Intravenous infusion, hydration; each additional hour	<1%	9,475	$628K
J0178	Injection, aflibercept, 1 mg	<1%	495	$623K
83735		<1%	76,262	$622K
87536		<1%	7,051	$615K
73090		<1%	8,263	$608K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	6,151	$608K
J3490	Unclassified drugs	<1%	43,115	$604K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	5,092	$597K
76801		<1%	5,857	$589K
74018		<1%	8,576	$578K
92567		<1%	12,901	$576K
99204	Doctor's office visit, new patient (more involved)	<1%	5,810	$558K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,955	$553K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	7,802	$547K
71250		<1%	4,094	$537K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	10,250	$527K
93975		<1%	3,713	$523K
84484		<1%	34,902	$518K
36415	Collection of venous blood by venipuncture	<1%	65,241	$514K
86850		<1%	25,894	$499K
20552		<1%	3,725	$497K
36430		<1%	2,430	$490K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	1,357	$488K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	5,675	$480K
73564		<1%	4,415	$471K
73221		<1%	1,525	$467K
76830	Ultrasound, transvaginal	<1%	5,186	$459K
84100		<1%	81,913	$455K
81001		<1%	80,304	$454K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	11,147	$440K
90832	Psychotherapy session, about 30 minutes	<1%	8,064	$436K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	5,962	$429K
72100		<1%	5,283	$427K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	9,728	$427K
96376		<1%	13,236	$425K
76825		<1%	810	$423K
76000		<1%	2,977	$421K
80053	Comprehensive metabolic panel	<1%	51,696	$419K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	7,306	$419K
86780		<1%	20,482	$413K
87481		<1%	10,424	$405K
97542		<1%	2,497	$404K
96416		<1%	2,403	$398K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	964	$398K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	4,054	$394K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	4,736	$393K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	6,777	$384K
72110		<1%	4,169	$383K
96415		<1%	6,047	$383K
93320		<1%	5,598	$382K
97602		<1%	6,509	$381K
93971		<1%	4,165	$381K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	14,614	$379K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	976	$376K
96417		<1%	4,190	$376K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	4,254	$371K
83880		<1%	13,639	$370K
92579		<1%	3,335	$368K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	5,404	$364K
82077		<1%	12,385	$363K
72197		<1%	811	$363K
83690		<1%	41,716	$362K
87040		<1%	11,147	$360K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	13,319	$359K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	4,043	$358K
70491		<1%	1,394	$357K
54161		<1%	246	$357K
29075		<1%	2,248	$354K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	2,905	$353K
73552		<1%	5,194	$344K
84439		<1%	28,235	$343K
51102		<1%	457	$341K
77073		<1%	2,949	$337K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	2,153	$335K
96367		<1%	6,458	$335K
83970		<1%	8,120	$333K
90834	Psychotherapy session, about 45 minutes	<1%	4,225	$332K
83655		<1%	7,565	$329K
90461		<1%	7,900	$323K
44970		<1%	110	$318K
90791	Psychiatric diagnostic evaluation	<1%	3,196	$318K
80074		<1%	4,761	$314K
29405		<1%	1,751	$312K
67028	Intravitreal injection of a pharmacologic agent	<1%	1,834	$311K
82728		<1%	18,652	$310K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	7,487	$310K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,215	$310K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	10,694	$309K
76642		<1%	3,125	$307K
77336		<1%	2,923	$298K
86803		<1%	14,733	$297K
93970		<1%	2,331	$296K
29581		<1%	5,684	$294K
90715		<1%	13,900	$288K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,770	$287K
72146		<1%	897	$287K
76536		<1%	3,098	$285K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	3,455	$282K
73060		<1%	4,431	$279K
86480		<1%	5,650	$278K
88307		<1%	2,172	$277K
74181		<1%	795	$276K
36591		<1%	7,694	$276K
73502		<1%	4,909	$274K
96127		<1%	6,859	$274K
C1769	Guide wire	<1%	5,220	$274K
97535	Self-care/home management training, each 15 minutes	<1%	9,794	$273K
82803		<1%	10,170	$273K
72072		<1%	3,398	$270K
94060		<1%	2,409	$268K
87077		<1%	20,459	$266K
92134		<1%	8,738	$265K
92526		<1%	3,281	$264K
99173		<1%	3,932	$264K
87522	Neg quan hep c or qual rna	<1%	4,298	$263K
86160		<1%	6,286	$263K
81025		<1%	18,165	$260K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	12,084	$252K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	2,894	$252K
74178		<1%	1,104	$252K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	6,619	$251K
G0009	Administration of pneumococcal vaccine	<1%	13,351	$251K
86235		<1%	3,126	$250K
86140		<1%	38,874	$249K
72050		<1%	2,628	$248K
G0384	Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	1,165	$248K
82570		<1%	35,861	$244K
72158		<1%	551	$244K
99172		<1%	1,845	$243K
77334		<1%	1,021	$241K
64615		<1%	2,049	$237K
77063	Screening digital breast tomosynthesis, bilateral	<1%	3,980	$236K
83605		<1%	16,327	$228K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	4,823	$226K
88185		<1%	853	$225K
88342		<1%	5,124	$225K
76870		<1%	1,870	$224K
94760		<1%	14,481	$224K
85610		<1%	49,515	$223K
72156		<1%	502	$221K
J2704	Injection, propofol, 10 mg	<1%	22,117	$220K
95812		<1%	1,247	$212K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	2,303	$211K
58300		<1%	1,262	$211K
97760		<1%	3,994	$207K
67311		<1%	110	$206K
69210		<1%	2,299	$205K
52000		<1%	575	$202K
76820		<1%	2,784	$202K
87186		<1%	15,918	$202K
87653		<1%	4,261	$201K
29065		<1%	1,153	$198K
97163		<1%	2,698	$197K
43264		<1%	271	$194K
99442		<1%	3,665	$194K
84403		<1%	6,488	$193K
17110		<1%	1,926	$190K
C1889	Implantable/insertable device, not otherwise classified	<1%	1,103	$189K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	54,967	$188K
72195		<1%	469	$187K
80305		<1%	17,008	$187K
76813		<1%	2,933	$186K
93226		<1%	1,638	$183K
36592		<1%	5,768	$183K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	94	$183K
97161		<1%	8,097	$178K
96116		<1%	1,036	$175K
94660		<1%	2,244	$175K
81514		<1%	1,593	$174K
92083		<1%	3,371	$174K
94729		<1%	2,554	$171K
92610		<1%	2,102	$170K
92133		<1%	4,603	$170K
97162		<1%	4,441	$169K
86147		<1%	1,561	$166K
86361		<1%	5,817	$164K
82607		<1%	9,896	$164K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	7,268	$163K
31231		<1%	1,197	$163K
93017		<1%	934	$162K
64721		<1%	184	$160K
77080		<1%	2,653	$160K
82785		<1%	2,620	$159K
77066	Tomosynthesis, mammo	<1%	1,852	$159K
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	<1%	8,543	$159K
74230		<1%	1,857	$158K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	941	$157K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	18,776	$156K
L1960	Ankle foot orthosis, posterior solid ankle, plastic, custom fabricated	<1%	317	$155K
31575		<1%	1,121	$155K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	16,068	$154K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	15,670	$153K
82043		<1%	14,852	$153K
94726		<1%	1,375	$153K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	3,670	$152K
96409		<1%	1,610	$151K
51798		<1%	3,962	$151K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	6,292	$151K
83520		<1%	5,272	$151K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	47,157	$148K
83550		<1%	14,824	$148K
11102		<1%	1,071	$145K
36416		<1%	13,740	$144K
87340		<1%	10,077	$143K
49083		<1%	696	$142K
12001		<1%	1,393	$140K
77412		<1%	1,342	$140K
77301		<1%	157	$138K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,606	$138K
86923		<1%	2,181	$137K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	352	$137K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	30,012	$137K
82784		<1%	8,528	$135K
99153	Mod sedat endo service >5yrs	<1%	7,637	$134K
96900		<1%	4,643	$134K
47562		<1%	56	$134K
51701		<1%	1,732	$133K
J9035	Injection, bevacizumab, 10 mg	<1%	58	$131K
80143		<1%	6,105	$130K
77065	Tomosynthesis, mammo	<1%	1,860	$129K
12002		<1%	1,284	$129K
80179		<1%	6,013	$127K
83540		<1%	16,376	$127K
99205	Prolong outpt/office vis	<1%	980	$126K
11981		<1%	687	$125K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	4,297	$125K
97116		<1%	3,898	$124K
82670		<1%	3,821	$124K
94761		<1%	4,455	$123K
86900		<1%	28,032	$123K
92555		<1%	1,152	$123K
12011		<1%	1,141	$121K
43259		<1%	288	$120K
85730		<1%	16,556	$120K
92611		<1%	1,501	$120K
87480		<1%	4,701	$119K
87510		<1%	4,702	$119K
87660		<1%	4,702	$119K
72040		<1%	1,332	$118K
88304		<1%	3,886	$118K
86901		<1%	28,073	$118K
76886		<1%	1,099	$116K
93923		<1%	1,549	$114K
H2010	Comprehensive medication services, per 15 minutes	<1%	861	$114K
83516		<1%	5,131	$114K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,818	$114K
85652		<1%	31,611	$114K
J2997	Injection, alteplase recombinant, 1 mg	<1%	645	$113K
G0008	Administration of influenza virus vaccine	<1%	14,366	$112K
84156		<1%	23,163	$111K
90670		<1%	10,775	$111K
90474		<1%	5,178	$110K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	1,269	$110K
72190		<1%	1,108	$109K
58301		<1%	458	$109K
96161		<1%	2,858	$109K
73000		<1%	1,550	$107K
J7050	Infusion, normal saline solution, 250 cc	<1%	10,964	$107K
J2560	Injection, phenobarbital sodium, up to 120 mg	<1%	2,800	$107K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	178	$106K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	1,616	$106K
72157		<1%	243	$106K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	5,348	$105K
82805		<1%	2,544	$104K
99080		<1%	27,972	$104K
64642		<1%	415	$103K
86038		<1%	6,828	$102K
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	<1%	2,835	$102K
82378		<1%	4,263	$101K
77300		<1%	437	$100K
88312		<1%	1,642	$100K
87632		<1%	432	$99K
74174		<1%	305	$99K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	8,519	$99K
92558		<1%	1,801	$99K
95700		<1%	503	$97K
87799		<1%	2,453	$96K
69209		<1%	1,469	$96K
97113		<1%	630	$95K
96119		<1%	230	$94K
90732		<1%	1,246	$94K
83615		<1%	10,784	$93K
90651		<1%	4,322	$92K
J1453	Injection, fosaprepitant, 1 mg	<1%	758	$92K
J9070	Cyclophosphamide, 100 mg	<1%	186	$92K
J8501	Aprepitant, oral, 5 mg	<1%	936	$92K
10060		<1%	983	$92K
25600		<1%	564	$91K
97802		<1%	1,540	$90K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,661	$90K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	34,037	$89K
87070		<1%	5,716	$89K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	1,126	$89K
G0382	Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	925	$89K
54640		<1%	39	$88K
81002		<1%	13,631	$88K
97803		<1%	2,131	$88K
86225		<1%	5,034	$87K
J2426	Injection, paliperidone palmitate extended release (invega sustenna), 1 mg	<1%	16	$86K
36000		<1%	5,941	$86K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	2,114	$86K
99152		<1%	3,905	$86K
95886		<1%	1,124	$86K
82550		<1%	9,921	$86K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,678	$85K
88313		<1%	1,555	$85K
82248		<1%	8,481	$85K
87902		<1%	275	$85K
82105		<1%	4,124	$85K
97167		<1%	996	$83K
80197		<1%	6,160	$82K
96401		<1%	2,076	$82K
96523		<1%	2,174	$82K
99443		<1%	1,192	$82K
95713		<1%	212	$82K
97165		<1%	3,437	$82K
96411		<1%	1,622	$81K
99606		<1%	3,237	$80K
95782		<1%	86	$80K
92652		<1%	316	$79K
82565		<1%	14,351	$79K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	447	$78K
84480		<1%	4,423	$78K
72081		<1%	934	$78K
92582		<1%	612	$78K
73560		<1%	1,182	$77K
84460		<1%	9,720	$77K
J0690	Injection, cefazolin sodium, 500 mg	<1%	15,087	$77K
G0010	Administration of hepatitis b vaccine	<1%	3,792	$77K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	2,895	$76K
84270		<1%	4,368	$76K
J1631	Injection, haloperidol decanoate, per 50 mg	<1%	1,183	$76K
73523		<1%	591	$76K
96118		<1%	237	$76K
82746		<1%	4,662	$76K
64483		<1%	224	$75K
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	890	$74K
86762		<1%	5,083	$74K
J0475	Injection, baclofen, 10 mg	<1%	285	$74K
86146		<1%	1,526	$73K
85384		<1%	6,438	$73K
70543		<1%	153	$73K
87650		<1%	1,623	$73K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	7,476	$72K
82140		<1%	4,082	$72K
84450		<1%	9,418	$72K
43244		<1%	164	$71K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	35,085	$71K
86787		<1%	5,503	$71K
94618		<1%	803	$70K
73140		<1%	1,003	$70K
93225		<1%	1,345	$69K
11976		<1%	162	$69K
84153		<1%	3,632	$68K
76942		<1%	941	$67K
85379		<1%	4,756	$67K
86706		<1%	4,856	$66K
11900		<1%	641	$66K
78816		<1%	70	$65K
J1815	Injection, insulin, per 5 units	<1%	3,343	$64K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	4,645	$64K
96450		<1%	265	$63K
76827		<1%	534	$62K
70355		<1%	1,523	$62K
73700		<1%	301	$62K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	707	$62K
76882		<1%	648	$60K
83001		<1%	2,374	$59K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	15	$59K
11104		<1%	418	$58K
86945		<1%	589	$58K
70360		<1%	909	$58K
84146		<1%	2,203	$58K
11100		<1%	546	$57K
H2011	Crisis intervention service, per 15 minutes	<1%	2,094	$56K
93246		<1%	1,132	$56K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	1,941	$56K
82247		<1%	4,000	$56K
70487		<1%	198	$55K
J9190	Injection, fluorouracil, 500 mg	<1%	1,971	$55K
85018		<1%	8,598	$53K
86800		<1%	2,433	$53K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,939	$53K
95813		<1%	309	$53K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	349	$53K
86356		<1%	379	$53K
86870		<1%	387	$52K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	99	$51K
26055		<1%	70	$51K
86708		<1%	3,308	$51K
99496		<1%	674	$51K
51702		<1%	999	$51K
86430		<1%	4,136	$50K
82977		<1%	5,116	$50K
86334		<1%	1,176	$49K
74022		<1%	537	$49K
86376		<1%	2,253	$49K
87497		<1%	1,647	$49K
86704		<1%	4,109	$48K
87338		<1%	2,702	$48K
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	3,253	$46K
J1644	Injection, heparin sodium, per 1000 units	<1%	7,673	$46K
87505		<1%	1,433	$46K
96160		<1%	1,222	$45K
95951		<1%	91	$45K
86200		<1%	2,880	$45K
87205		<1%	6,720	$44K
64493		<1%	102	$44K
94727		<1%	518	$44K
97166		<1%	1,490	$44K
86304		<1%	1,529	$43K
76937		<1%	728	$42K
93321		<1%	1,827	$42K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	7,942	$42K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	2,500	$42K
87075		<1%	2,540	$42K
86355		<1%	1,231	$42K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	502	$41K
84550		<1%	7,035	$41K
77077		<1%	376	$41K
83002		<1%	1,737	$41K
94664		<1%	504	$41K
81373		<1%	193	$40K
70544		<1%	123	$40K
87206		<1%	2,944	$39K
86255		<1%	2,000	$39K
57454		<1%	184	$39K
84481		<1%	1,889	$39K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	41	$39K
85246		<1%	1,124	$39K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	10,178	$39K
81375		<1%	132	$38K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	1,305	$38K
90677		<1%	804	$38K
86359		<1%	589	$38K
77295		<1%	38	$38K
88184		<1%	935	$38K
87529		<1%	598	$38K
96139		<1%	300	$38K
70250		<1%	454	$37K
43762		<1%	184	$37K
58661		<1%	16	$37K
C1726	Catheter, balloon dilatation, non-vascular	<1%	325	$37K
95251		<1%	1,325	$37K
96402		<1%	1,597	$37K
C9399	Unclassified drugs or biologicals	<1%	976	$37K
88112		<1%	1,576	$37K
90785		<1%	4,901	$36K
84305		<1%	1,143	$36K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,856	$36K
88720		<1%	3,984	$36K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	12,213	$36K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,121	$36K
87102		<1%	2,507	$35K
77338		<1%	229	$35K
88341		<1%	2,070	$35K
92523		<1%	353	$34K
L4361	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf	<1%	254	$34K
93880		<1%	349	$34K
85014		<1%	9,789	$34K
92250		<1%	557	$34K
20550		<1%	253	$34K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	382	$33K
99177		<1%	2,437	$33K
80164		<1%	1,540	$33K
84134		<1%	1,910	$32K
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	1,755	$32K
36593		<1%	293	$32K
92585		<1%	132	$32K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	1,571	$32K
95117		<1%	1,185	$32K
81508		<1%	1,168	$31K
95956		<1%	58	$31K
87631		<1%	230	$31K
86256		<1%	2,103	$31K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	10,676	$30K
84165		<1%	2,861	$30K
17000		<1%	664	$30K
82330		<1%	1,983	$29K
72052		<1%	315	$29K
82610		<1%	2,276	$29K
96132		<1%	176	$29K
99495		<1%	509	$29K
L2840	Addition to lower extremity orthosis, tibial length sock, fracture or equal, each	<1%	429	$28K
67228		<1%	70	$28K
90792	Psychiatric diagnostic evaluation with medical services	<1%	353	$28K
74019		<1%	255	$27K
J3480	Injection, potassium chloride, per 2 meq	<1%	3,115	$27K
J9045	Injection, carboplatin, 50 mg	<1%	833	$27K
83993		<1%	1,704	$26K
85613		<1%	1,518	$26K
77091		<1%	925	$26K
92551		<1%	445	$26K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,745	$26K
86360		<1%	470	$26K
85049		<1%	4,832	$25K
86665		<1%	500	$25K
92552		<1%	227	$25K
82075		<1%	1,016	$25K
25605		<1%	73	$24K
90473		<1%	1,201	$24K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	3,491	$24K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	3,540	$24K
86300		<1%	758	$24K
86258		<1%	2,608	$24K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,696	$24K
84145		<1%	1,498	$23K
86039		<1%	1,696	$23K
84445		<1%	329	$23K
72070		<1%	288	$23K
77072		<1%	263	$23K
80299		<1%	1,048	$23K
71101		<1%	247	$23K
86364		<1%	2,607	$23K
87116		<1%	1,350	$22K
80177		<1%	2,035	$22K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	420	$22K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,076	$22K
99607		<1%	896	$21K
64450		<1%	49	$21K
90734		<1%	3,107	$21K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	41	$21K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,929	$21K
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)	<1%	248	$21K
J1953	Injection, levetiracetam, 10 mg	<1%	1,274	$21K
82533		<1%	1,095	$21K
82085		<1%	1,498	$20K
88300		<1%	1,731	$20K
29125		<1%	165	$20K
89051		<1%	2,019	$20K
97763		<1%	313	$20K
92524		<1%	173	$19K
83521		<1%	1,691	$19K
82950		<1%	3,974	$19K
95115		<1%	772	$19K
20605		<1%	135	$19K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	307	$19K
20611		<1%	116	$19K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	1,899	$19K
H0033	Oral medication administration, direct observation	<1%	68	$19K
J3489	Injection, zoledronic acid, 1 mg	<1%	361	$19K
87015		<1%	1,841	$19K
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	88	$18K
64566		<1%	216	$18K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,113	$18K
J9171	Injection, docetaxel, 1 mg	<1%	76	$18K
81003		<1%	3,333	$18K
82040		<1%	4,009	$18K
11721		<1%	511	$18K
80180		<1%	1,848	$17K
83721		<1%	1,418	$17K
J9370	Vincristine sulfate, 1 mg	<1%	1,178	$17K
86828		<1%	883	$17K
A0427	Emergency ambulance ride, advanced life support	<1%	114	$17K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,244	$17K
45381		<1%	60	$16K
93798		<1%	455	$16K
93271		<1%	157	$16K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	3,865	$16K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	6,150	$16K
43760		<1%	93	$16K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	36	$16K
82951		<1%	1,063	$15K
93296		<1%	721	$15K
H0020	Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)	<1%	3,016	$15K
J2060	Injection, lorazepam, 2 mg	<1%	6,135	$15K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	13	$15K
74455		<1%	97	$15K
87641		<1%	671	$15K
C1874	Stent, coated/covered, with delivery system	<1%	27	$15K
82150		<1%	1,565	$15K
85048		<1%	4,191	$15K
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,720	$15K
81511		<1%	398	$14K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	748	$14K
90686		<1%	8,420	$14K
J7300	Intrauterine copper contraceptive (paragard)	<1%	13	$14K
74021		<1%	160	$14K
86357		<1%	514	$14K
95991		<1%	181	$13K
93299		<1%	467	$13K
92025		<1%	318	$13K
J3411	Injection, thiamine hcl, 100 mg	<1%	1,076	$13K
90746		<1%	194	$13K
92081		<1%	287	$13K
93356		<1%	113	$13K
93308		<1%	64	$13K
74241		<1%	115	$12K
92553		<1%	98	$12K
64643		<1%	128	$12K
99406		<1%	744	$12K
17003		<1%	170	$12K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	335	$12K
29515		<1%	140	$12K
95911		<1%	106	$12K
87901		<1%	45	$12K
91320		<1%	314	$12K
C9257	Injection, bevacizumab, 0.25 mg	<1%	537	$12K
90480		<1%	1,050	$11K
64494		<1%	67	$11K
88173		<1%	265	$11K
86592		<1%	1,966	$11K
51700		<1%	121	$11K
31579		<1%	50	$11K
99441		<1%	376	$11K
80175		<1%	765	$11K
11982		<1%	40	$11K
87486		<1%	303	$11K
70480		<1%	66	$11K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	3,162	$11K
J1790	Injection, droperidol, up to 5 mg	<1%	2,384	$11K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	247	$10K
58100		<1%	110	$10K
84466		<1%	744	$10K
A0434	Specialty care transport (sct)	<1%	81	$10K
D1208	Topical application of fluoride, excluding varnish	<1%	104	$10K
86301		<1%	453	$10K
43273		<1%	16	$10K
90688		<1%	710	$10K
87581		<1%	305	$10K
84432		<1%	548	$10K
88108		<1%	296	$10K
J9267	Injection, paclitaxel, 1 mg	<1%	600	$10K
87449		<1%	921	$10K
87324		<1%	571	$10K
52287		<1%	12	$10K
92609		<1%	278	$9K
92504		<1%	649	$9K
95250		<1%	76	$9K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	2,032	$9K
A0425	Ground mileage, per statute mile	<1%	610	$9K
49082		<1%	37	$9K
84436		<1%	978	$9K
51741		<1%	171	$9K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	1,147	$9K
82390		<1%	723	$9K
C9113	Injection, pantoprazole sodium, per vial	<1%	1,739	$9K
87081		<1%	658	$9K
36561		<1%	14	$9K
90685		<1%	4,552	$9K
J2800	Injection, methocarbamol, up to 10 ml	<1%	578	$8K
26720		<1%	57	$8K
84112		<1%	210	$8K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	922	$8K
91065		<1%	57	$8K
77001		<1%	231	$8K
84520		<1%	1,794	$8K
95819		<1%	49	$8K
99383		<1%	72	$8K
92588		<1%	90	$8K
97164		<1%	384	$8K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	453	$8K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	72	$8K
88360		<1%	67	$8K
97598		<1%	195	$7K
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	26	$7K
99195		<1%	116	$7K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	806	$7K
92228		<1%	118	$7K
11056		<1%	110	$7K
64616		<1%	56	$7K
92560		<1%	1,118	$7K
T1502	Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit	<1%	2,394	$7K
96138		<1%	336	$7K
82947		<1%	1,069	$7K
76519		<1%	163	$7K
T1016	Case management, each 15 minutes	<1%	136,468	$7K
76821		<1%	77	$7K
82397		<1%	460	$7K
26600		<1%	42	$6K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	19	$6K
L3807	Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	88	$6K
87328		<1%	328	$6K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	1,591	$6K
J3111	Injection, romosozumab-aqqg, 1 mg	<1%	12	$6K
94626		<1%	124	$6K
80195		<1%	331	$6K
89220		<1%	194	$6K
H0038	Self-help/peer services, per 15 minutes	<1%	277	$6K
78306		<1%	25	$6K
96368		<1%	243	$6K
84681		<1%	193	$6K
80178		<1%	558	$6K
73720		<1%	14	$5K
29105		<1%	62	$5K
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	866	$5K
73600		<1%	59	$5K
J1630	Injection, haloperidol, up to 5 mg	<1%	1,434	$5K
J1940	Injection, furosemide, up to 20 mg	<1%	1,618	$5K
97010		<1%	608	$5K
86880		<1%	553	$5K
86036		<1%	739	$5K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	459	$5K
92227		<1%	145	$5K
J0670	Injection, mepivacaine hydrochloride, per 10 ml	<1%	1,080	$5K
64644		<1%	25	$5K
11719		<1%	111	$5K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	12	$5K
90716		<1%	2,580	$5K
92136		<1%	106	$5K
72202		<1%	57	$5K
93280		<1%	202	$5K
77290		<1%	14	$5K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	171	$5K
99201		<1%	209	$5K
49450		<1%	13	$5K
11101		<1%	77	$5K
72114		<1%	47	$5K
99384		<1%	43	$5K
87906		<1%	45	$5K
84157		<1%	821	$5K
84590		<1%	273	$5K
90621		<1%	614	$5K
86352		<1%	25	$5K
64405		<1%	29	$5K
87517		<1%	119	$4K
77075		<1%	28	$4K
88377		<1%	15	$4K
86593		<1%	1,107	$4K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	3,860	$4K
87329		<1%	364	$4K
82945		<1%	707	$4K
84425		<1%	282	$4K
72131		<1%	26	$4K
94668		<1%	100	$4K
84155		<1%	1,313	$4K
85240		<1%	142	$4K
73070		<1%	57	$4K
83498		<1%	137	$4K
84446		<1%	297	$4K
75635		<1%	12	$4K
80156		<1%	180	$4K
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	<1%	309	$4K
88311		<1%	515	$4K
92556		<1%	68	$4K
77076		<1%	39	$4K
97032		<1%	110	$4K
87900		<1%	40	$4K
76512		<1%	52	$4K
84132		<1%	515	$4K
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,950	$4K
85520		<1%	157	$4K
G0381	Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	54	$3K
85651		<1%	541	$3K
51600		<1%	85	$3K
74240		<1%	37	$3K
82627		<1%	126	$3K
80069		<1%	483	$3K
82164		<1%	138	$3K
G0444	Annual depression screening, 5 to 15 minutes	<1%	256	$3K
80185		<1%	155	$3K
85046		<1%	1,446	$3K
90707		<1%	2,560	$3K
Q2039	Influenza virus vaccine, not otherwise specified	<1%	214	$3K
86381		<1%	226	$3K
85045		<1%	510	$3K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	18	$3K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	117	$3K
80230		<1%	189	$3K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	371	$3K
78264		<1%	13	$3K
29345		<1%	13	$3K
D7140	Extraction, erupted tooth or exposed root	<1%	14	$3K
86015		<1%	416	$3K
89050		<1%	629	$3K
12053		<1%	12	$3K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,130	$3K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	59	$3K
C2628	Catheter, occlusion	<1%	42	$3K
92520		<1%	38	$3K
95910		<1%	38	$3K
92225		<1%	70	$3K
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	371	$3K
95873		<1%	40	$3K
90636		<1%	44	$3K
71271		<1%	28	$3K
77081		<1%	271	$3K
29126		<1%	48	$3K
82340		<1%	272	$2K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,677	$2K
72220		<1%	40	$2K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	18	$2K
J2400	Injection, chloroprocaine hydrochloride, per 30 ml	<1%	132	$2K
96381		<1%	148	$2K
93926		<1%	27	$2K
86148		<1%	84	$2K
74170		<1%	12	$2K
82104		<1%	138	$2K
73620		<1%	32	$2K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	31	$2K
87899		<1%	95	$2K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	50	$2K
76514		<1%	83	$2K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	378	$2K
11720		<1%	56	$2K
85245		<1%	43	$2K
72080		<1%	26	$2K
82952		<1%	821	$2K
85004		<1%	276	$2K
86141		<1%	111	$2K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	512	$2K
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	307	$2K
88172		<1%	75	$2K
A6211	Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing	<1%	31	$2K
86341		<1%	82	$2K
77280		<1%	12	$2K
J9250	Methotrexate sodium, 5 mg	<1%	270	$2K
C1729	Catheter, drainage	<1%	33	$2K
76885		<1%	13	$2K
95977		<1%	13	$2K
93985		<1%	13	$2K
27750		<1%	12	$2K
84478		<1%	232	$2K
C1780	Lens, intraocular (new technology)	<1%	1,480	$2K
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	421	$2K
64612		<1%	14	$2K
90632		<1%	29	$2K
82310		<1%	264	$2K
87184		<1%	77	$2K
86008		<1%	13	$2K
86645		<1%	76	$2K
82232		<1%	144	$2K
72192		<1%	12	$2K
74220		<1%	24	$2K
C1781	Mesh (implantable)	<1%	15	$2K
86316		<1%	83	$1K
86777		<1%	67	$1K
12013		<1%	16	$1K
J1756	Injection, iron sucrose, 1 mg	<1%	63	$1K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	155	$1K
85130		<1%	132	$1K
L0984	Protective body sock, prefabricated, off-the-shelf, each	<1%	27	$1K
95909		<1%	25	$1K
96136		<1%	65	$1K
99407		<1%	95	$1K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	46	$1K
87088		<1%	190	$1K
73503		<1%	12	$1K
82024		<1%	40	$1K
82274		<1%	82	$1K
J2598	Injection, vasopressin, 1 unit	<1%	91	$1K
88302		<1%	56	$1K
80145		<1%	55	$1K
95874		<1%	42	$1K
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	98	$1K
0296T		<1%	28	$1K
99156		<1%	25	$1K
88740		<1%	103	$1K
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	<1%	12	$1K
95012		<1%	28	$1K
A4315	Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone	<1%	43	$1K
76604		<1%	13	$1K
86644		<1%	49	$1K
88237		<1%	13	$1K
83020		<1%	46	$1K
82103		<1%	63	$1K
87176		<1%	171	$987.53
84075		<1%	176	$981.28
17250		<1%	50	$962.99
90700		<1%	809	$918.18
90648		<1%	3,074	$903.04
97018		<1%	50	$884.68
99151		<1%	41	$880.30
J7999	Compounded drug, not otherwise classified	<1%	40	$859.96
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	64	$842.78
0141U		<1%	104	$839.02
74270		<1%	12	$830.83
86696		<1%	28	$804.09
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	134	$791.03
80183		<1%	90	$784.31
J9260	Injection, methotrexate sodium, 50 mg	<1%	57	$774.34
46600		<1%	12	$748.57
88350		<1%	12	$746.44
77012		<1%	12	$724.71
J2471	Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg	<1%	185	$718.63
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	16	$699.36
J1171	Injection, hydromorphone, 0.1 mg	<1%	247	$698.67
84300		<1%	148	$694.15
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	132	$687.72
91200		<1%	41	$685.64
0552T		<1%	14	$682.89
77002		<1%	38	$620.91
82955		<1%	44	$617.04
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	23	$590.22
86663		<1%	28	$574.06
95908		<1%	13	$570.40
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	12	$566.10
J1836	Injection, metronidazole, 10 mg	<1%	74	$566.08
92082		<1%	16	$549.41
82365		<1%	27	$549.14
86695		<1%	28	$526.42
93298		<1%	98	$522.26
84244		<1%	25	$505.52
86308		<1%	52	$504.15
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	395	$486.35
86337		<1%	26	$464.74
77417		<1%	41	$447.50
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	204	$444.34
84154		<1%	25	$441.49
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	12,846	$437.20
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	33	$433.83
96137		<1%	13	$432.25
92060		<1%	15	$431.01
G0380	Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	12	$423.73
88346		<1%	12	$416.63
86618		<1%	13	$408.18
86664		<1%	16	$403.38
80203		<1%	52	$387.22
82139		<1%	12	$363.22
S0280	Medical home program, comprehensive care coordination and planning, initial plan	<1%	9,124	$348.01
80202		<1%	19	$343.81
83921		<1%	14	$339.58
86580		<1%	36	$338.64
88142		<1%	12	$337.87
82465		<1%	53	$331.17
86705		<1%	26	$328.11
80235		<1%	26	$320.13
86735		<1%	28	$307.67
82525		<1%	25	$304.95
92020		<1%	14	$303.67
80201		<1%	13	$301.65
83010		<1%	16	$281.17
88331		<1%	15	$280.31
82653		<1%	24	$276.88
84144		<1%	12	$272.89
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	43	$265.82
82375		<1%	12	$265.28
90698		<1%	6,827	$263.05
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	<1%	28	$244.96
97016		<1%	25	$239.41
J0173	Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg	<1%	92	$230.80
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	31	$218.49
86060		<1%	17	$215.86
83006		<1%	56	$197.41
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	12	$186.82
83937		<1%	12	$180.60
82523		<1%	32	$165.70
90713		<1%	84	$157.68
82962		<1%	42	$148.80
82010		<1%	12	$144.98
86765		<1%	13	$141.06
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	42	$138.46
87147		<1%	14	$131.27
90633		<1%	5,346	$119.27
98960		<1%	12	$118.80
90744		<1%	3,017	$107.18
A6260	Wound cleansers, any type, any size	<1%	13	$97.26
83930		<1%	12	$83.77
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	360	$80.00
J3430	Injection, phytonadione (vitamin k), per 1 mg	<1%	16	$79.98
84133		<1%	18	$76.57
G0127	Trimming of dystrophic nails, any number	<1%	27	$70.92
J0290	Injection, ampicillin sodium, 500 mg	<1%	28	$67.22
J2720	Injection, protamine sulfate, per 10 mg	<1%	15	$64.21
90696		<1%	2,085	$42.54
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	<1%	13	$42.49
81015		<1%	16	$34.53
90680		<1%	6,636	$32.25
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	130	$28.06
V2632	Posterior chamber intraocular lens	<1%	250	$19.33
90723		<1%	2,655	$0.97
90710		<1%	2,396	$0.86
90647		<1%	44	$0.04
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	339	$0.00
J2590	Injection, oxytocin, up to 10 units	0%	32	$0.00
90681		0%	14	$0.00
0159T		0%	13	$0.00
T2030	Assisted living, waiver; per month	0%	48	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	24	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	99	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWHITE, BONNIE (CHIEF FINANCIAL OFFICER)

Same official

Other billing entities under WHITE, BONNIE

Full network →

Provider	Location	Paid
Unm Hospital	Albuquerque, NM	$17.62M
Unm Hospital	Albuquerque, NM	$283K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.